Loading insider details...
Latest Form 4 (Oct 13, 2026): Conversion of 5,637 RTSN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Retension Pharmaceuticals, Inc. (RTSN) | Conversion | 5,637 | n/a |
| Sep 5, 2023 | Acasti Pharma Inc. (ACST) | Purchase | 381 | $781.05 |
| Jul 18, 2023 | Acasti Pharma Inc. (ACST) | Grant/Award | 12,500 | n/a |
| Sep 30, 2022 | Acasti Pharma Inc. (ACST) | Grant/Award | 45,000 | n/a |
| Nov 16, 2021 | Acasti Pharma Inc. (ACST) | Grant/Award | 42,100 | n/a |